|
2010
|
Invention
|
Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin pr... |
|
2008
|
Invention
|
Protease variants for pharmaceutical use. The invention relates to novel variants of a protease d... |
|
|
Invention
|
Novel process for separating and determining the viral load in a pancreatin sample. Processes for... |
|
|
Invention
|
Novel sulfamate compounds for medical use. This invention relates to sulfamates of Formula (I), w... |
|
|
Invention
|
Sulfamate compounds and uses thereof.
A sulfamate compound corresponding to Formula I
A sulfam... |
|
|
Invention
|
C11 modified retrosteroids as progesterone receptor modulator compounds.
Retrosteroidal compound... |
|
|
Invention
|
Novel c11 modified retrosteroids as progesterone receptor modulator compounds. Described herein a... |
|
|
Invention
|
H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states. The use... |
|
2007
|
Invention
|
Lipase variants for pharmaceutical use. The pharmaceutical use of lipases related to the Thermomy... |
|
|
Invention
|
Substituted estratriene derivatives as 17beta hsd inhibitors. Substituted estratriene compounds o... |
|
|
Invention
|
Substituted estratrien derivatives as 17beta hsd inhibitors. This invention relates to novel subs... |
|
|
Invention
|
Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors. This in... |
|
|
Invention
|
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-n-acetic acid comp... |
|
|
Invention
|
Pharmaceutical combination comprising an adenosine a1 antagonist and a radiocontrast media.
Desc... |
|
|
Invention
|
Use of adenosine a1 antagonists in radiocontrast media induced nephropathy.
Described herein are... |
|
|
Invention
|
Use of adenosine a1 antagonist in radiocontrast media induced nephropathy. The present invention ... |
|
|
Invention
|
Long term 24 hour intestinal administration of levodopa/carbidopa. A method of treating Parkinson... |
|
|
Invention
|
Process for separating and determining the viral load in a pancreatin sample. Processes for separ... |
|
|
Invention
|
Use of cbx cannabinoid receptor modulators as potassium channel modulators.
Methods of treating ... |
|
|
Invention
|
Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel ... |
|
|
Invention
|
Use of cbx cannabinoid receptor modulators as potassium channel modulators. The invention is dire... |
|
|
Invention
|
Dual nk2/nk3-antagonists, pharmaceutical compositions comprising them, and processes for their pr... |
|
|
Invention
|
Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for the... |
|
|
Invention
|
Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods.
Use of bacterial strai... |
|
|
Invention
|
Process for the preparation of 11beta-hydr0xy-9beta, 10alpha -steroids employing amycolatopsis me... |
|
2006
|
Invention
|
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions. T... |
|
|
Invention
|
Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related condit... |
|
|
Invention
|
Nk1 and nk2-antagonists and compositions and methods of using the same. 3-cyanonaphthalene-1-carb... |
|
|
Invention
|
Novel nk1 and nk2 antagonists. The present invention relates to novel 3-cyano-naphthalene-1-carbo... |
|
|
Invention
|
N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases. The present invention r... |
|
|
Invention
|
Novel c18 modified retrosteroids as progesterone receptor modulator compounds.
Retrosteroidal c... |
|
|
Invention
|
Novel c18 modified retrosteroids as progesterone receptor modulator compounds. Described herein a... |
|
|
Invention
|
Methods of using potassium channel inhibiting compounds.
Described herein are methods of treatin... |
|
|
Invention
|
Method of using potassium channel inhibiting compounds. The present invention relates to the use ... |
|
|
Invention
|
Pancreatin micropellet cores suitable for enteric coating. Described herein are a process for man... |
|
|
Invention
|
Controlled release pharmaceutical compositions for acid labile drugs. An enteric-coated oral dosa... |
|
|
Invention
|
Processes for the manufacture of sterilized pancreatin powder. Disclosed is a process for the man... |
|
|
Invention
|
Screening methods for inhibitors of the metalloprotease meprin. Compounds that regulate the zinc ... |
|
|
Invention
|
Proteases for pharmaceutical use.
The pharmaceutical use of proteases related to amino acids 1-2... |
|
|
Invention
|
Proteases for pharmaceutical use. The pharmaceutical use of proteases related to amino acids 1-27... |
|
|
Invention
|
Lipases for pharmaceutical use. The pharmaceutical use of lipases related to a variant of the The... |
|
|
Invention
|
Amylases for pharmaceutical use. The pharmaceutical use of amylases related to Bacillus alpha-amy... |
|
|
Invention
|
Arrhythmogenic risk management tools and methods of use.
Novel approaches to identifying and man... |
|
|
Invention
|
Torsadogenic risk management tool. The present invention relates to a novel approach to identifyi... |
|
|
Invention
|
17&bgr;-hsd1 and sts inhibitors. The present invention relates to novel substituted steroid deriv... |
|
|
Invention
|
Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using... |
|
|
Invention
|
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-n-acetic acid comp... |
